Wells Fargo & Co Increases Edwards Lifesciences (EW) Price Target to $170.00

Wells Fargo & Co Increases Edwards Lifesciences (EW) Price Target to $170.00


The firm presently has an "outperform" rating on the medical research company's stock. Wells Fargo & Co's price objective would indicate a potential upside of 19.83% from the company's current price.



from Biotech News